Prevention of post-ERCP pancreatitis: a comprehensive review (Q35790308)

10 August 2017

1 reference

title

Prevention of post-ERCP pancreatitis: a comprehensive review (English)

1 reference

10 August 2017

Martin L Freeman

1

1 reference

PubMed ID

15173799

10 August 2017

Nalini M Guda

series ordinal

2

1 reference

PubMed ID

15173799

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Gastrointestinal Endoscopy

10 August 2017

1 reference

10 August 2017

59

1 reference

10 August 2017

7

1 reference

10 August 2017

845-864

1 reference

Endoscopic sphincterotomy complications and their management: an attempt at consensus

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Risk factors for post-ERCP pancreatitis: a prospective, multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Complications of endoscopic biliary sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Bedside scoring system to predict the risk of developing pancreatitis following ERCP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Predictors of post-ERCP complications in patients with suspected choledocholithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Risk factors for complications after performance of ERCP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Risk Factors for Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography: A Meta-Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic sphincterotomy for stones by experts is safe, even in younger patients with normal ducts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Precut papillotomy--a risky technique for experts only

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Needle-knife access papillotomy: an unfairly maligned technique?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Benefits and risks of needle-knife papillotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Prevention of post-ERCP pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A prospective assessment of results for needle-knife papillotomy and standard endoscopic sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Needle knife papillotomy in a university referral practice. Safety and efficacy of a modified technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Long-term experience with the transpancreatic sphincter pre-cut approach to biliary sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Needle-knife sphincterotomy in a tertiary referral center: efficacy and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Needle-knife papillotomy: a helpful and safe adjunct to endoscopic retrograde cholangiopancreatography in a selected population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

An assessment of the learning curve for precut biliary sphincterotomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: A prospective randomized controlled multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic sphincteroclasy: a useful therapeutic tool for biliary endoscopy in Billroth II gastrectomy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatitis induced by endoscopic balloon sphincter dilation and changes in serum amylase levels after the procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A sphincterotome-based technique for selective transpapillary common bile duct cannulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Comparison of Standard and Steerable Catheters for Bile Duct Cannulation in ERCP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

First cut, then blend: an electrocautery technique affecting bleeding at sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve selective bile duct cannulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Safety and outcome of endoscopic snare excision of the major duodenal papilla.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic management of tumors of the major duodenal papilla: Refined techniques to improve outcome and avoid complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic therapy of benign tumors of the papilla of Vater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic management of adenoma of the major duodenal papilla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatitis after sphincter of Oddi manometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with the perfusion manometry technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Incidence and risk factors for biliary and pancreatic stent migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pancreatic stents can induce ductal changes consistent with chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Endoscopic Management of Pancreatic Disorders: Potential Risks of Pancreatic Prostheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Post-ERCP pancreatitis: reduction by routine antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A randomised, prospective study comparing two contrast media in ERCP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Hyperamylasemia after ERCP with ionic and non-ionic contrast media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Use of corticosteroids in the prevention of post-ERCP pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Interleukin 10 reduces the severity of acute pancreatitis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Interleukin 10 prevents necrosis in murine experimental acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Effect of somatostatin analog octreotide on human sphincter of Oddi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

Features that may predict hospital admission following outpatient therapeutic ERCP

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2804%2900353-0

10.1016/S0016-5107(04)00353-0

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15173799